Evidence map›Paper›PMID 41647933›Full record

ArticleAfrican journal of laboratory medicine2026

The β-goblin gene architecture in individuals with and without sickle cell disease in Nigeria: Implications for β-thalassaemia trait diagnosis.

Oluwatoyin A Babalola, Biobele J Brown, Foluke Fasola, Jing Zhang, Yonglan Zheng, Abayomi B Odetunde, Adeyinka G Falusi, Olufunmilayo Olopade

Abstract read
In one paragraph

Article in African journal of laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oluwatoyin A BabalolaInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID https://orcid.org/0000-0002-4979-8135
Biobele J BrownDepartment of Paediatrics, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID https://orcid.org/0000-0001-6981-9872
Foluke FasolaDepartment of Haematology, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID https://orcid.org/0000-0002-5841-9678
Jing ZhangSection of Hematology/Oncology, Department of Medicine, University of Chicago, Illinois, Chicago, United States.ORCID https://orcid.org/0009-0003-3332-8571
Yonglan ZhengSection of Hematology/Oncology, Department of Medicine, University of Chicago, Illinois, Chicago, United States.ORCID https://orcid.org/0000-0001-6597-7072
Abayomi B OdetundeInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID https://orcid.org/0000-0001-6513-1165
Adeyinka G FalusiInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID https://orcid.org/0000-0002-3064-3336
Olufunmilayo OlopadeSection of Hematology/Oncology, Department of Medicine, University of Chicago, Illinois, Chicago, United States.ORCID https://orcid.org/0000-0002-9936-1599

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: β-thalassaemia is considered rare in Africa; however, recent screening-based studies suggest a β-thalassaemia trait prevalence of 6% - 10% among individuals with sickle cell disease (SCD) and up to 25% in those without SCD. Co-inheritance with SCD may modify disease severity, highlighting the need for molecular confirmation. Objective: To ascertain the prevalence and genetic basis of β-thalassaemia trait in Nigerians with and without SCD. Methods: We recruited 260 participants (130 per group; aged 3 years - 69 years, median [interquartile range] = 16 [9-29]). Haemoglobin fractions were analysed using high-performance liquid chromatography, and full blood counts were obtained. A 1.6 kb region of the β-globin gene was amplified and sequenced by Sanger sequencing. Variants were annotated and haplotypes constructed. An additional 26 samples from a separate SCD cohort were also genotyped. Results: Molecular analysis revealed a β-thalassaemia trait prevalence of < 1% in both groups, contrasting with recent screening-based reports. In addition to sickle cell, haemoglobin C, and β-thalassaemia mutations, eight other variants were identified, three of which were unique to SCD patients and in linkage disequilibrium. Sickle cell and haemoglobin C mutations occurred on the major ancestral haplotype, whereas the only β-thalassaemia mutation detected (rs33915217C>A) was associated with a minor ancestral haplotype atypical of Africa. Two rare variants (rs537944366T>C and rs33915217C>A) are reported for the first time in the Yoruba population. Conclusion: These findings indicate a low prevalence of β-thalassaemia trait in Nigeria and underscore the need to re-evaluate diagnostic approaches in African populations for optimal clinical management of SCD and other anaemias. What this study adds: This study provides the first molecular confirmation of the low prevalence of β-thalassaemia trait in the Yoruba population. It identifies two rare variants, including a β-thalassaemia mutation on a minor, atypical haplotype, and highlights the limitations of high-performance liquid chromatography, underscoring the importance of genetic testing for accurate diagnosis.

Indexed as

haplotypeNigeriasickle cell diseasevariantsYoruba populationβ-globin geneβ-thalassaemia trait

Identifiers

PMID41647933
PMCPMC12869452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.